Table 2 Patient characteristics (n=46)

From: A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer

Characteristics

No. of patients

Assessable for response

46

Gender

 

 Male

18

 Female

28

Age, years

 

 Median

57

 Range

24–77

WHO performance status

 

 0

13

 1

29

 2

4

Prior therapy

 

 Chemotherapy

44

 Radiotherapy

7

 Hormonal or biological therapy

13

Tumour type

 

 Ovary

16

 Melanoma

6

 Colorectal

5

 Kidney

5

 Lung

3

 Oesophagus

2

 Thyroid

2

 Gastrointestinal stroma tumour

1

 Neuroendocrine tumour

1

 Cholangiocarcinoma

1

 Leiomyosarcoma of the uterus

1

 Testis

1

 Primary peritoneal carcinoma

1

 Fallopian tube

1

  1. Abbreviation: WHO=World Health Organization.